微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 6.47% | -36% | 48.39% | 10/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 4.36% | -13.83% | 109.62% | 10/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 2.08% | -20.61% | -81.53% | 9/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 11.26% | 7.03% | 11.37% | 13/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 10.11% | 39.64% | 99.8% | 13/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 5.06% | -0.59% | 93.13% | 16/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 2.62% | -37.17% | -75.1% | 16/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 10.52% | -63.61% | 45.3% | 21/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 7.24% | 2% | 42.24% | 26/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 5.09% | -66.64% | 22.06% | 21/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 4.17% | 2% | -85.58% | 12/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 28.91% | 27.69% | 89.45% | 4/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-06-30 | 15.26% | 176.45% | -32.6% | 5/51 | 2.28% | 金域医学 | 43.58% | 行业排名> |
| 2020-12-31 | 22.64% | -55.84% | 310.14% | 14/51 | 10.95% | 金域医学 | 35.41% | 行业排名> |
| 2020-06-30 | 5.52% | -75.99% | -89.23% | 15/51 | 2.48% | 阳光诺和 | 26.2% | 行业排名> |
| 2019-12-31 | 51.27% | -6.87% | -6.87% | 4/51 | 65.31% | 金域医学 | 13.23% | 行业排名> |
| 2018-12-31 | 55.05% | -6.19% | 139.45% | 2/51 | -0.6% | 万邦医药 | 52.05% | 行业排名> |
| 2018-06-30 | 22.99% | -9.67% | -60.82% | 1/51 | 1.51% | 华大基因 | 48.52% | 行业排名> |
| 2017-12-31 | 58.68% | 2% | 130.57% | 1/51 | 1.73% | 华大基因 | 31.24% | 行业排名> |
| 2017-06-30 | 25.45% | 2% | 2% | 2/51 | 60.47% | 阳光诺和 | 13.99% | 行业排名> |